This scoping review examines the impact of Rezum therapy on sexual function in patients with benign prostatic hyperplasia (BPH). Analyzing 15 studies with 2,425 patients, the review finds that Rezum ...

Teleflex today announced new data highlighting the success of its UroLift benign prostatic hyperplasia (BPH) treatment system ...

MINNEAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of ...

Teleflex (TFX) announced that new findings from the CLEAR study were presented at the 40th Annual European Association of Urology Congress in ...

Among the results, the study showed better early patient satisfaction and sexual function with the UroLift™ System (PUL) compared to Rezūm™ Water Vapor Therapy (WVTT). 1 CLEAR is the first ...